Thursday, April 17, 2014 12:52:17 AM
From previous filings on OTC (Revenue/Net Income)
March '13 Qtr: 5k; -393k
June '13 Qtr:45k; -354k
Sep '13 Qtr: 7k; -219k
YTD Sep '13: 57k; -966k
Annual Financials from 16/04/2014 (OTC)
Full Year '13: 53k; -1911k
This means in Dec quarter (= Full Year - YTD Sep'13) company reversed 4k revenues and had expenses of 945k.
Great performance!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM